PubMed Health⌕ Search

PubMed · 10149149

Comparative physical tests on segmented polyurethanes for cardiovascular applications.

Abstract

In order to select a candidate segmented polyurethane (SPU) elastomer for cardiovascular prostheses, a series of physical tests was carried out on five commercially available biomedical polyurethanes. The tests were performed on uniformly thick sheets (0.2-0.3 mm), obtained by solvent casting from THF (Cardiothane 51, Pellethane 2363 80A, Estane 5714 F1, and Estane 58810) or DMAC (Biomer). Tensile mechanical tests at 23 and 37 degrees C showed for all the copolymers typical stress/strain behaviour of elastomeric materials, with small individual differences. Hydrolytic stability was investigated at 85, 60, and 37 degrees C, at increasing times of exposure (96-168 h), in water or alkaline buffer (pH = 10). As indicated by gel permeation chromatography, in almost all cases a degradation of the molecular weight (particularly the M w) was noticed after the hydrolytic tests, but tensile, thermal (by DSC) and dynamic mechanical properties were substantially not affected. SEM was also performed on the materials, before and after the hydrolytic tests. Changes in the morphology of the materials (related to degradation effects) was observed only in the case of Biomer, as shown also by the thermomechanical analyses. After this first series of physical tests, a clear choice of a particular SPU among the five investigated was not found.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M C Tanzi, L Ambrosio, L Nicolais, S Iannace, L Ghislanzoni, B Mambrito. 1991. Comparative physical tests on segmented polyurethanes for cardiovascular applications.. https://doi.org/10.1016/0267-6605(91)90010-d

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Percutaneous removal of a fractured endostent remnant from the portal vein.

We report the case of a liver transplant patient who developed a biliary stricture 3 years postoperatively which was treated with an endostent. During endoscopic removal, the stent fractured and a portion of it lodged itself within the intrahepatic portion of a portal vein branch. The endostent fragment was retrieved percutaneously using interventional radiology techniques. Risk factors for endostent fracture and migration as well as various percutaneous retrieval methods are reviewed in this article.

Blood Vessel Prosthesis↗

A biologically active VEGF construct in vitro: implications for bioengineering-improved prosthetic vascular grafts.

Prosthetic arterial grafts are unable to develop an intact endothelial lining after implantation, predisposing them to fail. Strategies have been sought to enhance endothelialization using growth factors and cytokines. This study assessed the biologic activity of vascular endothelial growth factor (VEGF) covalently linked to bovine serum albumin (BSA). Native and modified VEGF were assayed for endothelial cell migration and proliferation. Migration assays were performed comparing the effects of 2% fetal bovine serum (FBS), 50 ng/mL, 100 ng/mL, and 200 ng/mL of native VEGF and VEGF-BSA. Proliferation assays were performed by using Alamar Blue comparing cellular growth in 1% FBS, 10% FBS, 100 ng/mL unbound VEGF, and 100 ng/mL VEGF-BSA. VEGF is a potent chemotactic agent for endothelial cells in both unbound and bound states. Native VEGF solutions (50 ng/mL, 100 ng/mL, and 200 ng/mL) stimulated 23.9 cells/high power field (HPF), 35.3 cells/HPF, and 49.1 cells/HPF (p < 0.005). VEGF-BSA solutions stimulated 25.9 cells/HPF, 39.1 cells/HPF, and 69.0 cells/HPF (p < 0.001). VEGF-BSA and native VEGF supported similar increased cellular proliferation compared with 1% FBS media (p < 0.002). Modified VEGF retains its chemotactic and proliferative properties in vitro. These findings suggest that bare prosthetic surfaces lined with VEGF bound to a "basecoat" albumin may support endothelial cell proliferation and migration and thereby offer new strategies to improve graft patency.

Blood Vessel Prosthesis↗